Cancer of the Breast

Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals. Dr. Vivek Kumar Garg is an Associate Professor in the Department of Medical Lab Sciences at Rayat Bahra University, India. He earned his PhD in Neurology from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, and holds an M.Sc. in Medical Biochemistry. His research interests include cancer biology, genomics, epilepsy and neurological disorders, artificial intelligence in healthcare, biomarkers, clinical biochemistry, cardiovascular diseases, diabetes mellitus, and chronic kidney disease. His work focuses on the application of molecular, biochemical, and computational approaches to biomedical and translational research. He has contributed to research publications, academic books, and scholarly activities and has served as a reviewer and editorial board member for several international journals. Dr. Salman is Director of the Brown Center for Immunotherapy, Co-leader of the HHM CC Program, Don Brown Professor of Immunotherapy, and Professor of the Department of Medicine, Microbiology and Immunology, Indiana University, Indianapolis, IN 46202. She holds the MD and PhD in Medicine. She is on the editorial board of several journals with a high impact factor. She is mentioned as America’s most honored doctor (2020-2022). She has published several articles. Her expertise is in the engineering and manufacturing Chimeric Antigen Receptor T-cells (CAR-T cells) for treating hematological malignancies and solid tumors.

• 1. Epidemiology of breast cancer2. Risk factors for breast cancer: knowledge and prevention3. Histological and molecular classification of breast cancer: Basic understanding4. Breast cancer stromal and its components: implication in diagnostic and therapeutic5. Genetic behind breast cancer: Germline and somatic factors6. Heterogeneity of breast cancer: a major cause of therapy failure7. Recent advancement in molecular tools for breast cancer diagnosis and trends in future perspective8. Recent development in treatment strategies for breast cancer: With special reference to immunotherapy9. Liquid biopsy: A non-invasive tool in breast cancer diagnosis10. Protein biomarkers in breast cancer: Implication in diagnosis and prognosis11. Understanding of therapeutic resistance: With special resistance to breast cancer12. Breast Cancer Stem Cell: Role in Carcinogenesis13. Plant derived biomolecules: role in breast cancer initiation and progression